• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与产后进展性新冠疾病相关的预测性血液学和免疫学参数。

Predictive hematological and immunological parameters associated with postpartum progressed Covid-19 disease.

机构信息

Department of Infectious Diseases and Clinical Microbiology, University of Health Science, Gazi Yaşargil Education and Research Hospital, Diyarbakir, Turkey.

Department of Obstetrics and Gynecology, University of Health Science, Gazi Yaşargil Education and Research Hospital, Diyarbakir, Turkey.

出版信息

Afr Health Sci. 2021 Dec;21(4):1567-1573. doi: 10.4314/ahs.v21i4.10.

DOI:10.4314/ahs.v21i4.10
PMID:35283947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8889813/
Abstract

BACKGROUND

In pregnancy, Coronavirus disease-2019 (COVID-19) infection disease may be more severe due to existing physiological changes. Similarly, changes during and after birth can make the patient more subceptible.

OBJECTIVE

To investigate possible laboratory findings that was related to postpartum progression of COVID-19 disease.

METHODS

Pregnant women who are pregnant at 28 weeks or more and who are COVID-19 positive at the time of delivery were investigated in this study. Progressed post- delivery and non-progressed COVID-19 positive pregnants' laboratory findings were analyzed. Hematological and immunological parameters associated with postpartum progressed COVID-19 disease were evaluated.

RESULTS

Totally 151 individuals were conducted to the study. In the prenatal analysis, higher BMI and lower albumin levels were detected in the progressed group (p<0.05). In the postpartum analysis; White Blood Cell, lymphocyte and albumin were increased, while neutrophil, NLR, LDH, CK, D-DIMER, Ferritin, CRP and IL-6 were decreased in the non-progressed group as opposite of the progressed group (p<005).

CONCLUSION

We observed that prenatal low albumin and high BMI may be related to progression of the COVID-19 disease after delivery. In progressed group, inflammatory markers were increased after delivery while in non-progressed group they were improved. These markers may be warning for the postpartum progression of COVID-19 disease.

摘要

背景

由于存在生理变化,COVID-19 感染疾病在妊娠期间可能更为严重。同样,分娩期间和之后的变化也会使患者更容易受到影响。

目的

研究可能与 COVID-19 疾病产后进展相关的实验室发现。

方法

本研究调查了分娩时 COVID-19 阳性且妊娠 28 周或以上的孕妇。分析了产后进展和未进展 COVID-19 阳性孕妇的实验室检查结果。评估了与产后进展 COVID-19 疾病相关的血液学和免疫学参数。

结果

总共对 151 人进行了研究。在产前分析中,进展组的 BMI 较高且白蛋白水平较低(p<0.05)。在产后分析中,未进展组的白细胞、淋巴细胞和白蛋白增加,而中性粒细胞、NLR、LDH、CK、D-DIMER、铁蛋白、CRP 和 IL-6 下降,与进展组相反(p<0.05)。

结论

我们观察到产前低白蛋白和高 BMI 可能与产后 COVID-19 疾病的进展有关。在进展组中,炎症标志物在产后增加,而在未进展组中则改善。这些标志物可能是 COVID-19 疾病产后进展的预警。

相似文献

1
Predictive hematological and immunological parameters associated with postpartum progressed Covid-19 disease.与产后进展性新冠疾病相关的预测性血液学和免疫学参数。
Afr Health Sci. 2021 Dec;21(4):1567-1573. doi: 10.4314/ahs.v21i4.10.
2
The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.血液学和生化学参数在 2019 年冠状病毒病患者急诊科的预测和预后作用。
Chin J Physiol. 2021 Nov-Dec;64(6):306-311. doi: 10.4103/cjp.cjp_77_21.
3
Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis.巴基斯坦 SARS-COV-2 感染患者的血液学和生化学参数作为诊断和预后标志物:一项回顾性比较分析。
Hematology. 2021 Dec;26(1):529-542. doi: 10.1080/16078454.2021.1950898.
4
Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.新型冠状病毒感染患者血液学参数与疾病严重程度的相关性。
J Clin Lab Anal. 2021 Jan;35(1):e23604. doi: 10.1002/jcla.23604. Epub 2020 Nov 13.
5
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.新冠肺炎患者中性粒细胞与淋巴细胞比值和 D-二聚体的临床意义:中国苏州的一项回顾性研究。
Thromb Res. 2020 Aug;192:3-8. doi: 10.1016/j.thromres.2020.05.006. Epub 2020 May 6.
6
Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.新型冠状病毒肺炎的血液学、生物化学和免疫学检查结果解读:与严重程度和死亡率相关的生物标志物
Iran J Allergy Asthma Immunol. 2021 Feb 11;20(1):46-66. doi: 10.18502/ijaai.v20i1.5412.
7
The value of C-reactive protein/albumin, fibrinogen/albumin, and neutrophil/lymphocyte ratios in predicting the severity of CoVID-19.C 反应蛋白/白蛋白、纤维蛋白原/白蛋白和中性粒细胞/淋巴细胞比值在预测 CoVID-19 严重程度中的价值。
Rev Assoc Med Bras (1992). 2021 Mar;67(3):431-436. doi: 10.1590/1806-9282.20200883.
8
Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study.实验室指标对预测 COVID-19 患者疾病进展和死亡的临床价值:一项回顾性队列研究。
BMJ Open. 2021 Oct 1;11(10):e043790. doi: 10.1136/bmjopen-2020-043790.
9
[Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].[中性粒细胞与淋巴细胞比值在新型冠状病毒肺炎分型诊断中的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):554-558. doi: 10.3760/cma.j.cn121430-20200413-00506.
10
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.

本文引用的文献

1
Clinical characteristics and risk factors for mortality in obstetric patients with severe COVID-19 in Brazil: a surveillance database analysis.巴西产科重症 COVID-19 患者的临床特征和死亡风险因素:监测数据库分析。
BJOG. 2020 Dec;127(13):1618-1626. doi: 10.1111/1471-0528.16470. Epub 2020 Sep 14.
2
Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study.在纽约市对 SARS-CoV-2 进行普遍检测的人群中,妊娠和产后结局:一项前瞻性队列研究。
BJOG. 2020 Nov;127(12):1548-1556. doi: 10.1111/1471-0528.16403. Epub 2020 Aug 13.
3
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.中国 COVID-19 患者病情进展相关的纵向血液学和免疫学变化。
J Allergy Clin Immunol. 2020 Jul;146(1):89-100. doi: 10.1016/j.jaci.2020.05.003. Epub 2020 May 11.
4
Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women.3例女性患者产前感染新冠病毒肺炎产后病情加重
CMAJ. 2020 Jun 1;192(22):E603-E606. doi: 10.1503/cmaj.200553. Epub 2020 May 6.
5
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
6
Maternal death due to COVID-19.因 COVID-19 导致的产妇死亡。
Am J Obstet Gynecol. 2020 Jul;223(1):109.e1-109.e16. doi: 10.1016/j.ajog.2020.04.030. Epub 2020 Apr 28.
7
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China.中国武汉新冠肺炎孕妇的临床特征
N Engl J Med. 2020 Jun 18;382(25):e100. doi: 10.1056/NEJMc2009226. Epub 2020 Apr 17.
8
Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019.疑似新型冠状病毒肺炎孕妇的临床特征和结局。
J Infect. 2020 Jul;81(1):e40-e44. doi: 10.1016/j.jinf.2020.04.003. Epub 2020 Apr 12.
9
Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia.COVID-19 肺炎孕妇的放射学表现和临床特征。
Int J Gynaecol Obstet. 2020 Jul;150(1):58-63. doi: 10.1002/ijgo.13165. Epub 2020 Jun 3.
10
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.